Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Xoma
Welcome,
Profile
Billing
Logout
40 Products
215 Diseases
40 Products
125 Trials
4697 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
5
10
15
20
25
30
35
40
45
50
Raptiva
(efalizumab) / Roche, EMD Serono, Xoma
Vabysmo
(faricimab-svoa) / Roche
gevokizumab
(VPM087) / Novartis
aldoxorubicin
(INNO-206) / LadRx
vidutolimod
(CMP-001) / Regeneron
cetrelimab
(JNJ-63723283) / J&J
rilvegostomig
(AZD2936) / AstraZeneca
MK-4830
/ Merck (MSD)
Qinprezo
(vosaroxin) / Denovo
Agamree
(vamorolone) / Santhera
Ojemda
(tovorafenib) / Day One Biopharma
Ixinity
(trenonacog alfa) / Medexus
ficlatuzumab
(AV-299) / LG Chem
iscalimab
(CFZ533) / Novartis
nisevokitug
(NIS793) / Novartis
mezagitamab
(TAK-079) / Takeda
taminadenant
(NIR178) / Novartis
tuparstobart
(INCAGN2385) / Incyte
verzistobart
(INCAGN2390) / Incyte
PBF-680
/ Palobiofarma
acimtamig
(AFM13) / Affimed
Dsuvia
(sufentanil sublingual) / Alora Pharma
Miplyffa
(arimoclomol) / Orphazyme, Zevra Therap
RZ358
/ Rezolute
AFM24
/ Affimed
lucatumumab
(CHIR 12.12) / Novartis, Xoma
PBF-999
/ Palobiofarma
ProCase
(AB002) / Aronora
XOMA 213
/ Xoma
gruticibart
(AB023) / Bayer, Aronora
MNPR 101
/ Monopar Therap
PBF-1129
/ Palobiofarma
PBF-677
/ Palobiofarma
osocimab
(BAY 1213790) / Bayer
COM902
/ Compugen
KIN-3248
/ Xoma
PBF-1650
/ Palobiofarma
RZ402
/ Rezolute
ebopiprant
(OBE022) / Organon, Xoma
osocimab subcutaneous
(BAY 1213790 SC) / Bayer
